Detalles de la búsqueda
1.
Determination of phosphorylated proteins in tissue specimens requires high-quality samples collected under stringent conditions.
Histopathology
; 64(3): 431-44, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24266863
2.
Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial.
Front Oncol
; 13: 1157596, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207143
3.
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.
Clin Cancer Res
; 23(18): 5406-5415, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600476
4.
RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis.
Mol Cancer Ther
; 15(5): 946-57, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27037412
5.
Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors.
Clin Cancer Res
; 22(4): 858-67, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26446946
6.
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers.
Clin Cancer Res
; 21(2): 258-66, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25388164
7.
RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.
Clin Cancer Res
; 19(20): 5686-98, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23974006
8.
Extramedullary hematopoiesis in a pyogenic granuloma: a case report and review.
J Cutan Pathol
; 31(8): 555-7, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15268711
Resultados
1 -
8
de 8
1
Próxima >
>>